Last $72.95 USD
Change Today -0.46 / -0.63%
Volume 8.1M
MDT On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 2:24 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

medtronic plc (MDT) Snapshot

Open
$73.12
Previous Close
$73.41
Day High
$73.38
Day Low
$72.11
52 Week High
01/23/15 - $77.39
52 Week Low
02/4/14 - $53.33
Market Cap
103.4B
Average Volume 10 Days
15.1M
EPS TTM
$3.99
Shares Outstanding
1.4B
EX-Date
12/30/14
P/E TM
18.2x
Dividend
$1.22
Dividend Yield
1.65%
Current Stock Chart for MEDTRONIC PLC (MDT)

medtronic plc (MDT) Details

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group’s products include pacemakers; insertable cardiac monitors; implantable defibrillators; leads and delivery systems; ablation products; electrophysiology catheters; products for the treatment of atrial fibrillation; information systems for the management of patients with cardiac rhythm disease management devices; products to reduce surgical site infections; coronary and peripheral stents and related delivery systems; therapies for uncontrolled hypertension; endovascular stent graft systems; heart valve replacement technologies; cardiac tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Restorative Therapies Group offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; and systems that incorporate advanced energy surgical instruments. It also manufactures and sells image-guided surgery and intra-operative imaging systems. The Diabetes Group’s products include insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. The company serves hospitals, physicians, clinicians, and patients in approximately 140 countries. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.

49,247 Employees
Last Reported Date: 06/20/14
Founded in 1949

medtronic plc (MDT) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $1.5M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $774.9K
Executive Vice President and Group President ...
Total Annual Compensation: $724.9K
Executive Vice President and Group President ...
Total Annual Compensation: $675.1K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $781.7K
Compensation as of Fiscal Year 2014.

medtronic plc (MDT) Key Developments

Medtronic, Inc. Announces Board Changes

Medtronic, Inc. announced that on January 26, 2015, Richard H. Anderson, Scott C. Donnelly, Omar Ishrak, Shirley Ann Jackson, Michael O. Leavitt, James T. Lenehan, Elizabeth G. Nabel, Denise M. O’Leary, Kendall J. Powell, Robert C. Pozen and Preetha Reddy notified Medtronic of their decisions to resign from the board of directors of Medtronic effective immediately. Further, two directors were appointed to the Medtronic Board on January 26, 2015, effective immediately. Gary L. Ellis, has been Executive Vice President and Chief Financial Officer of Medtronic since April 2014. Mr. Ellis is a member of the board of directors of The Toro Company and past chairman of the American Heart Association. Bradley E. Lerman, joined Medtronic in May 2014 as Senior Vice President, General Counsel and Corporate Secretary. Prior to joining Medtronic, he was Executive Vice President, General Counsel, and Corporate Secretary at Federal National Mortgage Association (Fannie Mae).

Medtronic, Inc. Receives Certificate of Incorporation on Re-Registration as a Public Limited Company

On January 26, 2015, in connection with the consummation of the Transactions, Medtronic, Inc. received its Certificate of Incorporation on re-registration as a public limited company from the Companies Registration Office, Ireland in connection with its re-registration as a public limited company organized under the laws of Ireland, pursuant to which its name was changed from Medtronic Limited to Medtronic plc.

Medtronic, Inc.(NYSE:MDT) dropped from S&P 100 Index

Medtronic, Inc.(NYSE:MDT) dropped from S&P 100 Index

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $72.95 USD -0.46

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $44.95 USD +1.54
Allergan Inc/United States $221.53 USD -0.83
Astellas Pharma Inc ¥1,823 JPY +14.00
Becton Dickinson and Co $139.88 USD -0.94
Stryker Corp $93.05 USD +0.30
View Industry Companies
 

Industry Analysis

MDT

Industry Average

Valuation MDT Industry Range
Price/Earnings 25.4x
Price/Sales 4.2x
Price/Book 3.7x
Price/Cash Flow 22.2x
TEV/Sales 2.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC PLC, please visit www.medtronic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.